Literature DB >> 26611846

A view on glaucoma--are we seeing it clearly?

D P Crabb1.   

Abstract

Successful clinical management of glaucoma should not simply be about control of intraocular pressure, but must equate to correct decisions about intensifying treatment when patients are at risk of developing 'visual disability'. Yet little is known about what visual field defects, at different stages of glaucoma, specifically affect patients' abilities to perform everyday visual tasks. One way to do this is to measure patient performance in tasks in a lab setting. Another way is to ask patients themselves. The latter can be revealing and demystify views about how patients perceive the world. This short commentary highlights some of the current research in this area.

Entities:  

Mesh:

Year:  2015        PMID: 26611846      PMCID: PMC4763130          DOI: 10.1038/eye.2015.244

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  69 in total

1.  Views of glaucoma patients on aspects of their treatment: an assessment of patient preference by conjoint analysis.

Authors:  Jonathan S Bhargava; Bakula Patel; Alexander J E Foss; Anthony J Avery; Anthony J King
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-07       Impact factor: 4.799

2.  Patients have two eyes!: binocular versus better eye visual field indices.

Authors:  Ryo Asaoka; David P Crabb; Takehiro Yamashita; Richard A Russell; Ya Xing Wang; David F Garway-Heath
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-09-01       Impact factor: 4.799

3.  More Accurate Modeling of Visual Field Progression in Glaucoma: ANSWERS.

Authors:  Haogang Zhu; David P Crabb; Tuan Ho; David F Garway-Heath
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-09       Impact factor: 4.799

4.  Moving from PROMs to POEMs for glaucoma care: a qualitative scoping exercise.

Authors:  John E A Somner; Freda Sii; Rupert R Bourne; Vinette Cross; Jennifer M Burr; Peter Shah
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-08-31       Impact factor: 4.799

5.  Longitudinal changes in quality of life and rates of progressive visual field loss in glaucoma patients.

Authors:  Felipe A Medeiros; Carolina P B Gracitelli; Erwin R Boer; Robert N Weinreb; Linda M Zangwill; Peter N Rosen
Journal:  Ophthalmology       Date:  2014-10-16       Impact factor: 12.079

6.  Visual field staging systems in glaucoma and the activities of daily living.

Authors:  Kaushal M Kulkarni; Jason R Mayer; Luciano L Lorenzana; Jonathan S Myers; George L Spaeth
Journal:  Am J Ophthalmol       Date:  2012-05-24       Impact factor: 5.258

Review 7.  'Structure-function relationship' in glaucoma: past thinking and current concepts.

Authors:  Rizwan Malik; William H Swanson; David F Garway-Heath
Journal:  Clin Exp Ophthalmol       Date:  2012-04-12       Impact factor: 4.207

Review 8.  Practical recommendations for measuring rates of visual field change in glaucoma.

Authors:  B C Chauhan; D F Garway-Heath; F J Goñi; L Rossetti; B Bengtsson; A C Viswanathan; A Heijl
Journal:  Br J Ophthalmol       Date:  2008-01-22       Impact factor: 4.638

9.  A survey of attitudes of glaucoma subspecialists in England and Wales to visual field test intervals in relation to NICE guidelines.

Authors:  Rizwan Malik; Helen Baker; Richard A Russell; David P Crabb
Journal:  BMJ Open       Date:  2013-05-03       Impact factor: 2.692

10.  A qualitative study of stakeholder views regarding participation in locally commissioned enhanced optometric services.

Authors:  E Konstantakopoulou; R A Harper; D F Edgar; J G Lawrenson
Journal:  BMJ Open       Date:  2014-05-29       Impact factor: 2.692

View more
  17 in total

1.  More frequent, more costly? Health economic modelling aspects of monitoring glaucoma patients in England.

Authors:  Trishal Boodhna; David P Crabb
Journal:  BMC Health Serv Res       Date:  2016-10-22       Impact factor: 2.655

2.  Gradually Then Suddenly? Decline in Vision-Related Quality of Life as Glaucoma Worsens.

Authors:  Lee Jones; Susan R Bryan; David P Crabb
Journal:  J Ophthalmol       Date:  2017-04-02       Impact factor: 1.909

3.  Does the World Health Organization criterion adequately define glaucoma blindness?

Authors:  P Mokhles; Jsag Schouten; Hjm Beckers; Cab Webers
Journal:  Clin Ophthalmol       Date:  2017-03-02

Review 4.  Eye-Tracking as a Tool to Evaluate Functional Ability in Everyday Tasks in Glaucoma.

Authors:  Enkelejda Kasneci; Alex A Black; Joanne M Wood
Journal:  J Ophthalmol       Date:  2017-02-15       Impact factor: 1.909

5.  The effect of concentric constriction of the visual field to 10 and 15 degrees on simulated motor vehicle accidents.

Authors:  Sachiko Udagawa; Shinji Ohkubo; Aiko Iwase; Yuto Susuki; Shiho Kunimatsu-Sanuki; Takeo Fukuchi; Chota Matsumoto; Yuko Ohno; Hiroshi Ono; Kazuhisa Sugiyama; Makoto Araie
Journal:  PLoS One       Date:  2018-03-14       Impact factor: 3.240

6.  Data on eye movements in people with glaucoma and peers with normal vision.

Authors:  Daniel S Asfaw; Pete R Jones; Nicholas D Smith; David P Crabb
Journal:  Data Brief       Date:  2018-05-18

Review 7.  How do different lighting conditions affect the vision and quality of life of people with glaucoma? A systematic review.

Authors:  Jamie Enoch; Lee Jones; Deanna J Taylor; Carol Bronze; James F Kirwan; Pete R Jones; David P Crabb
Journal:  Eye (Lond)       Date:  2019-12-10       Impact factor: 3.775

8.  STARD 2015 was reproducible in a large set of studies on glaucoma.

Authors:  Gianni Virgili; Manuele Michelessi; Alba Miele; Francesco Oddone; Giada Crescioli; Valeria Fameli; Ersilia Lucenteforte
Journal:  PLoS One       Date:  2017-10-12       Impact factor: 3.240

9.  Impact of Glaucoma and Dry Eye on Text-Based Searching.

Authors:  Michelle J Sun; Gary S Rubin; Esen K Akpek; Pradeep Y Ramulu
Journal:  Transl Vis Sci Technol       Date:  2017-06-29       Impact factor: 3.283

10.  Scene and human face recognition in the central vision of patients with glaucoma.

Authors:  Alexia Roux-Sibilon; Floriane Rutgé; Florent Aptel; Arnaud Attye; Nathalie Guyader; Muriel Boucart; Christophe Chiquet; Carole Peyrin
Journal:  PLoS One       Date:  2018-02-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.